ICYMI (I did): #FDA has accepted the recommendation of its expert panel, #VRBPAC & recommended that Covid-19 vaccine manufacturers make a monovalent targeting the JN.1 lineage XFG variant. How will #CDC handle the change? It would normally go to #ACIP but it's in limbo. https://www.fda.gov/vaccines-blood-biologics/industry-biologics/covid-19-vaccines-2026-2027-formula-use-united-states-beginning-fall-2026